KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 26, 2019 PLENARY HALL - Auditorium I Auditorium VI+VII Auditorium VIII Auditorium II Auditorium V 08:30-17:30 PRE CONFERENCE SYMPOSIUM -COMMON FEATURES OF NEURODEGENERATIVE DISEASES: EXPLORING THE BRAIN-EYE CONNECTION AND BEYOND (08:30-17:00) PRE CONFERENCE SYMPOSIUM (08:30-17:00) THE PROMISE AND PITFALLS OF REAL-WORLD EVIDENCE IN ALZHEIMER'S DISEASE PRE CONFERENCE SYMPOSIUM -NEUROPATHOLOGY WORKSHOP (08:00-17:00) WEDNESDAY, MARCH 27, 2019 08:30-10:30 THE ALZHEIMER S DISEASE SEQUENCING PROJECT: PROGRESS AND PROMISE PREVENTION AND RESILIENCE IN DEMENTIA APOE MECHANISMS AND TREATMENT STRATEGIES TRANSLATIONAL TREATMENT STRATEGIES 1 IMAGING AND CSF BIOMARKERS CELLULAR MODELS 10:30-11:00 11:00 13:00 FLUID BIOMARKERS 1 CHOLINERGIC MECHANISMS IN AD AND PD NEUROPATHOLOGY AND ABETA TOXICITY SHORT ORAL PRESENTATIONS OF SELECTED POSTERS 11:00-11:45 GLUCOCEREBROSIDASE AND ALPHA-SYNUCLEIN TREM2 (1) 11:45-13:00 13:00 14:00 AD/PD 2019 BIOMARKERS AND IMAGING FORUM 14:00-15:00 14:00 16:40 (15:05-15:35) (15:40-16:10) VASCULAR DAMAGE IN DEMENTIA APP PROCESSING AND ABETA CLEARANCE 14:00 16:00 TREATMENTS OF TAUOPATHIES TRANSLATIONAL TREATMENT STRATEGIES 2 ALPHA-SYNUCLEIN DISEASE MECHANISMS 1 (16:15-16:40) 16:40-17:00 17:00-17:30 OPENING CEREMONY AND AWARDS 17:30-18:00 TREM2 FROM BASIC MECHANISMS TO HUMAN PATIENTS 18:00-18:30 HOW MICROGLIA WIRE AND UNWIRE THE BRAIN 18:30-19:00 WHAT WORKS AND DOESN'T WORK IN AD? 19:30 WELCOME RECEPTION
THURSDAY, MARCH 28, 2019 ROLE OF ALPHA-SYNUCLEIN AND LESSONS LEARNED FROM THE BRAIN TREATMENT STRATEGIES FOR PD AND DLB TREM2 (2) TAU STRUCTURE AND FUNCTION SHORT ORAL PRESENTATIONS OF SELECTED POSTERS MITOCHONDRIA, MAM AND ER 11:45-13:30 13:30-14:45 13:40-16:50 TURNING POINT MOVIE 13:40-15:40 AD/PD 2019 FORUM ON TRANSLATIONAL RESEARCH IN DRUG DISCOVERY FOR AD 15:50-16:50 IMAGING AND BIOMARKERS IN PD, LBD AND MSA ALPHA-SYNUCLEIN DISEASE MECHANISMS 2 C9ORF72 AND TDP-43 CALCIUM AND CELLULAR RESPONSES AD ANIMAL MODELS AND MECHANISTIC ASPECTS 16:50-17:20 17:20-19:20 BACE1 FUNCTION AND INHIBITION MOUSE MODELS OF AD GENETICS OF NEURODEGENERATION FLUID BIOMARKERS 2 TAU PATHOLOGY AND THERAPEUTIC STRATEGIES
FRIDAY, MARCH 29, 2019 THE CELL BIOLOGY OF SYNAPSE FORMATION AND SYNAPSE DEGENERATION ABETA IMMUNOTHERAPIES AND BACE 1 INHIBITORS TRANSLATIONAL TREATMENT STRATEGIES APP PROCESSING AND ABETA CLEARANCE SHORT ORAL PRESENTATIONS OF SELECTED POSTERS 09:15-10:10 PET IMAGING IMAGING, BIOMARKERS, DIAGNOSTIC AND MECHANISTIC ASPECTS IN PD, LBD 10:15-11:15 11:45-13:25 13:25-14:45 AD/PD 2019 FORUM ON NOVEL THERAPEUTIC STRATEGIES TO PD AND DLB 14:45-16:45 14:45-15:45 TAU PET IMAGING 1 PATHOPHYSIOLOGICAL MECHANISMS IN AD 16:45-17:15 CLINICAL FEATURES OF AD, VASCULAR DEMENTIA AND FTD TAU PROPAGATION AND CELLULAR INTERACTIONS AUTOPHAGY 17:15-19:15 MICROGLIA AND ASTROCYTES BIOMARKERS, IMAGING IN PD AND LBD LARKK.2 PARKIN ABETA AND TAU TOXICITY CONGOPHILIC AMYLOID ANGIOPATHY (CAA)
SATURDAY, MARCH 30, 2019 BIOMARKER ACTIVITIES IN ΑLPHA-SYNUCLEIN AGGREGATION DISORDERS NEUROPATHOLOGICAL CORRELATES IN PD MRI ANIMAL MODELS IN PD AND MOVEMENT DISORDERS SHORT ORAL PRESENTATIONS OF SELECTED POSTERS GENETIC MECHANISMS 11:45-13:25 UNDERSTANDING THE EFFECTS OF APOE ON THE PATHOGENESIS OF ALZHEIMER S DISEASE 13:25-14:45 AD/PD 2019 ALZHEIMER CLINICAL PHASE 3 FORUM 14:45-15:45 14:45-16:45 CLINICAL ASPECTS & THERAPEUTIC STRATEGIES IN PD BIOMARKERS AND IMAGING IN PD, LBD (2) BIOMARKERS AND IMAGING IN AD 1 (15:45-16:45) ALPHA-SYNUCLEINOPATHIES HUNTINGTON'S AND PRION DISEASES - THERAPEUTIC STRATEGIES CELLULAR TREATMENT STRATEGIES APOE: MECHANISMS 16:45-17:15 17:15-19:15 AD TREATMENT STRATEGIES DISEASE MECHANISMS IN AD, PD BIOMARKERS AND IMAGING IN AD (2) THE BIOCHEMICAL PROPERTIES AND CELLULAR EFFECTS OF PROTEOPATHIC ASSEMBLIES BRAIN GUT INTERACTIONS ALS AND FTD
SUNDAY, MARCH 31, 2019 09:00-09:30 MODULATION OF Abeta DEPOSITION BY THE MICROBIOME 09:30-09:45 09:45-11:45 DISEASE MECHANISMS, INFLAMMATION. MICROGLIA, AMYLOIDS BIOMARKERS IN AD AND MCI SYNAPTIC DYSFUNCTION IN ALZHEIMER DISEASE IMMUNE MECHANISMS NUTRITION TAU PROPAGATION AND CELLULAR INTERACTIONS 2 11:45-12:15 COFFEE 12:15-14:15 BIOMARKERS AND IMAGING IN AD 3 TAU PET IMAGING 2 ALPHA -SYNUCLEIN PATHOLOGY TRANSLATIONAL TREATMENT STRATEGIES 4 AD & PD: MECHANISMS AND THERAPEUTIC STRATEGIES LIPID AND MEMBRANE INTERACTIONS 14:15-14:30 CLOSING CEREMONY